DNTH Stock Analysis: Buy, Sell, or Hold?
DNTH - Dianthus Therapeutics, Inc. Common Stock
$53.18
-0.21 (-0.39%)
▼
5d:
+3.93%
30d:
+29.05%
90d:
+57.62%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 10, 2026
Get Alerted When DNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DNTH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DNTH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DNTH is currently trading at $53.18, which is considered extended relative to its 30-day fair value range of $39.06 to $49.73.
Technical Outlook: Technically, DNTH is in a strong uptrend. Immediate support is located at $42.70, while resistance sits at $57.50.
Market Sentiment: DNTH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $72.18 (+35.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DNTH is in a strong uptrend. Immediate support is located at $42.70, while resistance sits at $57.50.
Market Sentiment: DNTH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $72.18 (+35.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$39.06 -
$49.73
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
DNTH is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.9% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 35.7% below Wall St target ($72.18)
Fair Price Analysis
30-Day Fair Range
$39.06 -
$49.73
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$42.70
Resistance Level
$57.50
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-13.75
Wall Street Target
$72.18
(+35.7%)
Revenue Growth (YoY)
-81.8%
Last updated: February 02, 2026 10:17 PM ET
Data refreshes hourly during market hours. Next update: 11:17 PM
Data refreshes hourly during market hours. Next update: 11:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ryan Savitz
SELL
20000 shares
2025-09-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 56 HOLD |
Advanced DNTH Option Strategies
Professional options setups generated by AI based on today's DNTH price and gamma walls.
